Feinstein Institute
350 Community Drive
Manhasset
New York
11030
United States
Tel: 516-562-3467
112 articles about Feinstein Institute
-
Northwell Health Researcher Shows Vitamin D Could Improve Insulin-producing Cells in Children With Type 1 Diabetes
3/5/2024
Approximately 352,000 Americans under the age of 20 have type 1 diabetes, and every year 64,000 Americans more are diagnosed.
-
Feinstein Institutes Gets $3.1M NIH Grant to Further Understanding and Treatment of Psychiatric Illnesses Like ADHD, Schizophrenia, Autism
2/20/2024
Brain-based impairments in memory, reasoning and planning – collectively known as cognitive deficits – are present in several major neuropsychiatric disorders, most notably schizophrenia, affective disorders, autism spectrum disorders and attention-deficit/hyperactivity disorder.
-
Feinstein Institutes Leader Calls for a Federally-Funded, National Maternal Health Moonshot
12/22/2023
The United States has the highest maternal mortality rate among developed nations – with worse health outcomes for Black women and other minority groups.
-
Feinstein Institutes’ Dr. Christina Brennan honored with Clinical Trials Lifetime Achievement Award
12/20/2023
Northwell Health and the Feinstein Institutes for Medical Research’s Christina Brennan, MD, senior vice president of clinical research, has received the Clinical Trial Europe’s Christine Pierre Clinical Trials Lifetime Achievement Award for her dedication to leading innovative, equitable and clinically meaningful clinical trials throughout her career and particularly her leadership in rolling out some of the first national COVID-19 clinical trials in 2020.
-
Feinstein Institutes, Molecular Medicine award Dr. Peter Hotez with 2023 Cerami Award
12/14/2023
The Feinstein Institutes for Medical Research and Molecular Medicine announced that Peter Hotez, MD, PhD, a distinguished immunologist, pediatrician, and global health advocate, has been awarded the Anthony Cerami Award in Translational Medicine for his outstanding contributions to the field of molecular medicine and his dedication to addressing global health challenges.
-
Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize
11/2/2023
The Hans Wigzell Research Foundation announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research, is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
-
Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub
10/19/2023
Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
-
Feinstein Institutes secures $4M from NIH to study Black maternal health interventions
10/5/2023
From excessive bleeding to high blood pressure, even death, poor maternal health outcomes before or after delivery are at an all-time high across the United States, particularly for Black birthing people.
-
Feinstein Institutes’ Ross Prize awardees win 2023 Nobel Prize in Physiology or Medicine
10/2/2023
The Feinstein Institutes for Medical Research congratulates two scientists from the University of Pennsylvania Perelman School of Medicine, Katalin Karikó, PhD, and Drew Weissman, MD, PhD, for being awarded the 2023 Nobel Prize in Physiology or Medicine for their groundbreaking messenger RNA research that helped develop mRNA-based coronavirus disease 2019 vaccines.
-
Feinstein Institutes Study Warns of Looming Nationwide Shortage of General Internal Medicine Doctors
9/21/2023
There might be a lack of General Internal Medicine physicians by the year 2032, which could cause implications for health care and delivery across the United States.
-
Food and Drug Administration Approves First Postpartum Depression Pill, Research Led by Northwell Health’s Feinstein Institutes
8/7/2023
In a landmark decision, the U.S. Food and Drug Administration has approved the first at-home oral pill, zuranolone, which will be sold under the brand named Zurzuvae, for treating perinatal or postpartum depression – a condition one in eight birthing women experience.
-
For the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia
7/28/2023
In a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s The Feinstein Institutes for Medical Research have successfully implanted microchips into the brain of a man living with paralysis, and have developed artificial intelligence algorithms to re-link his brain to his body and spinal cord.
-
Feinstein Institutes’ Dr. Ping Wang Receives 2023 Mentor Award From the Shock Society
7/25/2023
Sepsis makes up nearly a quarter of deaths worldwide, often leading to shock and multiple organ failure.
-
Feinstein Institutes awarded $3.4M from Wellcome to study schizophrenia using rTMS therapy
4/28/2023
There might be a new, non-pharmacological way to treat major mental health disorders like schizophrenia spectrum disorders and psychosis.
-
NIH Awards $4.7M to Cohen Children’s Medical Center, Feinstein Institutes to Study Nephrotic Syndrome in Children
4/5/2023
The National Institutes of Health has awarded Northwell Health’s Cohen Children’s Medical Center and The Feinstein Institutes for Medical Research, the homes of pediatric research at Northwell, two grants totaling $4.73 million to study nephrotic syndrome – a kidney disorder that causes the body to pass too much protein into the urine – specifically in children.
-
Feinstein Institutes researchers turn on the vagus nerve, control the inflammatory reflex
1/18/2023
The vagus nerve runs from the human brainstem to major peripheral organs and acts as the main conduit for the body’s inflammatory immune response to disease, bacteria and viruses.
-
Feinstein Institutes lupus researchers recognized with top honors
11/17/2022
In recognition of their ongoing research and leadership in rheumatology, The Feinstein Institutes for Medical Research’s Betty Diamond, MD, and Anne Davidson, MBBS, have been awarded top honors by the American College of Rheumatology and the Association of Rheumatology Professionals.
-
New Digital Tool Dramatically Reduces Blood Clot Risk During and Post-Hospital Care, Feinstein Institutes Study Shows
11/7/2022
Every year, approximately 8 million Americans are susceptible to dangerous, often fatal blood clots when they are admitted to the hospital for a medical illness such as stroke or an infection like COVID-19.
-
High-frequency Electrical Stimulation Helps Reduce Inflammation, Pain in New Feinstein Institutes Study
10/5/2022
A bump, bruise or broken bone is painful. And while pain is an important defense mechanism to protect the body and promote healing, chronic pain can be debilitating.
-
Feinstein Institutes’ Betty Diamond receives Women in Medicine and Science Leadership Award
10/3/2022
For her dedication to empowering women in science, breakthrough achievements in molecular medicine and research contributions, The Feinstein Institutes for Medical Research’s Betty Diamond, MD, has been awarded the 2022 Association of American Medical Colleges Group on Women in Medicine and Science Leadership Award.